Bile Acid Activated Cell Signaling in the Liver and Nutrition

性状（由申请人提供）：胆汁酸是由肝细胞中的胆固醇合成的类固醇分子。它们的合成代表了从体内清除胆固醇的主要排泄途径。最近的研究表明，胆汁酸也作为强大的调节分子，帮助协调控制肝脏中的胆固醇、脂蛋白和葡萄糖代谢。胆汁酸能够通过两种不同但高度协调的细胞机制调节许多基因的表达和蛋白质的活性。它们可以激活特定的核受体（即FXR，PXR，维生素D）和细胞信号传导途径（即JNK1/2，ERK 1/2，AKT，蛋白激酶C）。每种胆汁酸似乎显示出一定程度的特异性，其激活的核受体和细胞信号传导途径，这表明胆汁酸池的组成可能是肝脏代谢的重要调节剂。当前资助更新申请的具体目的是：1）确定G蛋白偶联受体（GPCR）的身份，该受体通过ERBB1和胰岛素受体将原代肝细胞中的结合胆汁酸信号转导至ERK 1/2和AKT通路。确定百日咳毒素敏感GPCR信号引起原代肝细胞中ERBB1和胰岛素受体活化的分子机制。2)确定原代啮齿动物肝细胞和体内胆汁酸激活JNK 1/2途径的机制。确定不同的胆汁酸如何在体外激活酸性鞘磷脂酶（ASM）。3）。在慢性胆瘘大鼠和小鼠模型中表征不同胆汁酸对JNK1/2、ERK1/2和AKT信号通路的激活。确定不同胆汁酸输注（IV和ID）对细胞信号传导途径激活、选定脂质信号传导分子水平以及参与胆固醇和葡萄糖代谢的关键基因mRNA水平的影响。

DESCRIPTION (provided by applicant): Bile acids are steroid molecules that are synthesized from cholesterol in the liver hepatocytes. Their synthesis represents a major excretory pathway for removal of cholesterol from the body. Recent studies show that bile acids also function as powerful regulatory molecules helping to coordinately control cholesterol, lipoprotein, and glucose metabolism in the liver. Bile acids are able to regulate the expression of numerous genes and activities of proteins through 2 distinct, yet highly coordinated cellular mechanisms. They can activate specific nuclear receptors (i.e. FXR, PXR, Vitamin D) and cell signaling pathways (i.e. JNK1/2, ERK1/2, AKT, protein kinase C). Each bile acid appears to show some degree of specificity as to which nuclear receptor and cell signaling pathway that it activates, suggesting that the bile acid pool composition may be an important regulator of liver metabolism. The specific aims of the current grant renewal application are: 1) Determine the identity of the G protein coupled receptor(s) (GPCR), which transduces conjugated bile acid signaling in primary hepatocytes via ERBB1 and the insulin receptor, to ERK1/2 and AKT pathways. Determine the molecular mechanism(s) by which the pertussis toxin sensitive GPCR signal causes activation of ERBB1 and the insulin receptor in primary hepatocytes. 2) Determine the mechanism(s) of activation of the JNK1/2 pathway by bile acids in primary rodent hepatocytes and in vivo. Determine how different bile acids activate acidic sphingomyelinase (ASM) in vitro. 3). Characterize the activation of the JNK1/2, ERK1/2 and AKT signaling pathways by different bile acids in the chronic bile fistula rat and mouse models. Determine the effects of different bile acid infusion (IV and ID) on the activation of cell signaling pathways, levels of selected lipid signaling molecules, and mRNA levels of key genes involved in cholesterol and glucose metabolism.